Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01557010 | Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia | ||
| NCT07144176 | PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers | ||
| NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT05832697 | An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT06025409 | Evaluate the Efficacy and Safety of DWJ108J | ||
| NCT05926414 | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus | ||
| NCT01397240 | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients | ||
| NCT02693522 | Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency | ||
| NCT01713920 | Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM | ||
| NCT04185805 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) | ||
| NCT03573622 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT05816681 | Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea. | ||
| NCT05643508 | A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia | ||
| NCT03574285 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions | ||
| NCT04003441 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers | ||
| NCT03224117 | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT05661552 | Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI | ||
| NCT04721535 | A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2 | ||
| NCT06031987 | Long-term Effects of Flash Glucose Monitoring System in Patients With Gestational Diabetes | ||
| NCT05411887 | Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab | ||
| NCT04819932 | Pharmacokinetics and Safety of DWJ1451 in Healthy Adults | ||
| NCT00969787 | DWP05195 in Healthy Adult Male Volunteers | ||
| NCT02241850 | Genetic Polymorphisms Affecting Effect of High Intensity Training | ||
| NCT06751121 | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori | ||
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT03517319 | Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity | ||
| NCT03946592 | Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT05574374 | Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects | ||
| NCT02415777 | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction | ||
| NCT03947528 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions | ||
| NCT05660122 | A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT04888819 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT01094834 | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects | ||
| NCT02952755 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT04772443 | Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 | ||
| NCT07326904 | Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease | ||
| NCT02568150 | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | ||
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions | ||
| NCT01634321 | The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty | ||
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition. | ||
| NCT04524052 | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) |
